naringenin has been researched along with tamoxifen in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Dandriyal, J; Jaitak, V; Kumar, M; Singla, R | 1 |
| Gester, S; Kolba, S; Metz, P; Schwab, P; Vollmer, G; Wulf, M; Zierau, O | 1 |
| Hatkevich, T; Patel, YM; Ramos, J; Santos-Sanchez, I | 1 |
| Beg, S; Jain, S; Katare, OP; Kumar, R; Kushwah, V; Sandhu, PS; Singh, B | 1 |
| Huang, B; Liu, J; Luo, N; Pan, X; Wang, X; Wu, X; Xu, Z; Zheng, X | 1 |
| Jia, Y; Liu, J; Pan, X; Ren, X; Xia, X; Xu, Z; Yang, X | 1 |
1 review(s) available for naringenin and tamoxifen
| Article | Year |
|---|---|
Recent developments of C-4 substituted coumarin derivatives as anticancer agents.
Topics: Animals; Antineoplastic Agents; Coumarins; Humans | 2016 |
7 other study(ies) available for naringenin and tamoxifen
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Estrogenic activity of the phytoestrogens naringenin, 6-(1,1-dimethylallyl)naringenin and 8-prenylnaringenin.
Topics: Dose-Response Relationship, Drug; Estradiol Congeners; Estrogen Antagonists; Estrogens, Non-Steroidal; Flavanones; Flavonoids; Humans; Isoflavones; Molecular Structure; Phytoestrogens; Plant Preparations; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 2002 |
A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Proliferation; Estrogen Antagonists; Female; Flavanones; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Phosphorylation; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 2014 |
Natural lipids enriched self-nano-emulsifying systems for effective co-delivery of tamoxifen and naringenin: Systematic approach for improved breast cancer therapeutics.
Topics: Animals; Antineoplastic Agents, Hormonal; Biological Availability; Breast Neoplasms; Caco-2 Cells; Drug Delivery Systems; Emulsions; Flavanones; Humans; Lipids; Tamoxifen | 2017 |
Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Cell Cycle Proteins; Cell Division; Cell Movement; Drug Synergism; Estrogen Antagonists; Female; Flavanones; Humans; MCF-7 Cells; Reactive Oxygen Species; Receptors, Estrogen; Tamoxifen; Wound Healing | 2018 |
Naringenin and Quercetin Exert Contradictory Cytoprotective and Cytotoxic Effects on Tamoxifen-Induced Apoptosis in HepG2 Cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Hep G2 Cells; Humans; Quercetin; Reactive Oxygen Species; Tamoxifen | 2022 |